Wolfgang Wirth

Title: Wolfgang Wirth: Innovator in Pharmaceutical Compositions

Introduction

Wolfgang Wirth is a notable inventor based in Arisdorf, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalation therapies. With a total of 2 patents, Wirth's work focuses on improving the stability and efficacy of pharmaceutical compositions.

Latest Patents

Wirth's latest patents include innovative processes that enhance the delivery of glycopyrronium salt for inhalation. The first patent details a process for preparing dry powder formulations of glycopyrronium salt that maintain good stability. This process involves micronizing the glycopyrronium salt with an anti-adherent agent and then admixing carrier particles to create the final dry powder formulation. The second patent outlines a method for the micronization of pharmaceutically active agents, further advancing the field of pharmaceutical compositions.

Career Highlights

Wirth is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, contributing to the advancement of innovative therapies.

Collaborations

Some of Wirth's notable coworkers include Anton Baumberger and Gerhard Muhrer. Their collaborative efforts have played a crucial role in the development of new pharmaceutical solutions.

Conclusion

Wolfgang Wirth's contributions to pharmaceutical innovations, particularly in inhalation therapies, highlight his role as a key inventor in the industry. His patents reflect a commitment to improving patient outcomes through advanced drug formulations.